The Liaoning drug and medical consumables centralized procurement website has published the fourth round of volume-based procurement (VBP) winning bids among the “eight provinces and two regions.” The list includes a total of 18 drug specifications with an average price reduction of 59.53%, and is open for public feedback until December 21, 2022.
Inter-Provincial VBP Tender Details
The inter-provincial VBP tender, which took place on October 7, included products such as lentinan, creatine phosphate sodium, alprostadil, cefmenoxime, cefamandole, and betahistine, among a total of 18 specifications. Leading bid winners included Harbin Pharma, Chia Tai Tianqing Pharma, North China Pharma, and Yabao Pharma.
Bid Results and Price Reductions
No manufacturer won the bid for compound α-ketoacid. For acetylcysteine, Minsheng Pharma was the sole bidder, but its price reduction rate was above the average for all winning bids and therefore not accepted.-Fineline Info & Tech
